NCT03863990View on ClinicalTrials.gov

Study Performed at Various Medical Centers to Learn More About Survival and Expected Course of Pulmonary Arterial Hypertension, a Type of High Blood Pressure in the Lungs Related to the Narrowing of the Small Blood Vessels in the Lungs

CompletedOBSERVATIONAL
Enrollment

104

Participants

Timeline

Start Date

July 15, 2019

Primary Completion Date

May 11, 2020

Study Completion Date

May 11, 2020

Conditions
Pulmonary Arterial Hypertension
Interventions
DRUG

PAH medication

Any PAH-targeted medication

Trial Locations (1)

Unknown

Many facilities, Multiple Locations

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY

NCT03863990 - Study Performed at Various Medical Centers to Learn More About Survival and Expected Course of Pulmonary Arterial Hypertension, a Type of High Blood Pressure in the Lungs Related to the Narrowing of the Small Blood Vessels in the Lungs | Biotech Hunter | Biotech Hunter